Showing results (141-150 of 691) with videos related to
Sort By:
Pageof 70
Journal of the National Cancer Institute|November 1, 1979
Persistence and growth of rat liver neoplastic nodules following cessation of carcinogen exposureN Hirota, G M WilliamsMutation Research|November 1, 1988
The molecular nature of spontaneous and chemically induced mutations in the hypoxanthine-guanine phosphoribosyl transferase gene in rat liver epithelial cellsP Armel, G M WilliamsBiochemical Pharmacology|September 1, 1985
Activities of several phase I and phase II xenobiotic biotransformation enzymes in cultured hepatocytes from male and female ratsT Croci, G M WilliamsJournal of the National Cancer Institute|July 1, 1978
Quantitative kinetics of development of N-2-fluorenylacetamide-induced, altered (hyperplastic) hepatocellular foci resistant to iron accumulation and of their reversion or persistence following removal of carcinogenG M Williams, K WatanabePharmacology & Therapeutics|January 1, 1996
Butylated hydroxyanisole mechanistic data and risk assessment: conditional species-specific cytotoxicity, enhanced cell proliferation, and tumor promotionJ Whysner, G M WilliamsPharmacology & Therapeutics|January 1, 1996
2,3,7,8-Tetrachlorodibenzo-p-dioxin mechanistic data and risk assessment: gene regulation, cytotoxicity, enhanced cell proliferation, and tumor promotionJ Whysner, G M WilliamsToxicology and Applied Pharmacology|June 15, 1984
Neoplastic conversion in rat liver by the antihistamine methapyrilene demonstrated by a sequential syncarcinogenic effect with N-2-fluorenylacetamideK Furuya, G M WilliamsArchives of Toxicology|January 1, 1994
Comparison of DNA reactivity of the polyphenylethylene hormonal agents diethylstilbestrol, tamoxifen and toremifene in rat and hamster liverF Montandon, G M WilliamsCancer Research|June 1, 1982
Ultrastructural abnormalities in carcinogen-induced hepatocellular altered foci identified by resistance to iron accumulationN Hirota, G M WilliamsPneumologie (Stuttgart, Germany)|October 19, 2011
[Smoking cessation in pneumological routine care]Th Hering, J Andres, R Gebhardt, et al.Pageof 70